Revealing sit-downs with executives shaping the future of the global mining industry.
Episodes
Friday Sep 06, 2019
Friday Sep 06, 2019
Recent developments in gene therapy hold out hope for the treatment of a wide range of diseases, including fatal lung cancer.
Genprex Inc. (NASDAQ: GNPX) is focused on using gene therapy to tackle lung cancer, developing new drugs that can be used alongside existing treatments. Pfizer Inc. (NYSE: PFE) has created a state-of-the-art research center focused on gene therapy treatments, which it uses for illnesses including cancer. Gilead Sciences Inc. (NASDAQ: GILD) is using biotechnology to tackle a range of challenging diseases, including HIV and hepatitis. Sarepta Therapeutics Inc. (NASDAQ: SRPT) is developing 20 different genetic treatments for a wide range of diseases. Merck & Company Inc. (NYSE: MRK) has treatments in development for both prostate and lung cancer, offering further hope for those battling potentially fatal diseases.